Autolus Therapeutics (NASDAQ:AUTL – Get Free Report) released its earnings results on Tuesday. Autolus Therapeutics had a negative net margin of 311.98% and a negative return on equity of 128.59%. Autolus Therapeutics Stock PerformanceShares of AUTL stock traded up $0.17 during trading hours on Tuesday, hitting $2.23. Autolus Therapeutics has a 12 month low of $1.17 and a 12 month high of $2.50. Read MoreReceive News & Ratings for Autolus Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Autolus Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.